There is one new cases of COVID-19 to report in South East Zone 4, which includes Estevan, according to the daily report for June 11.
There were also two recoveries in Zone 4, leaving the total number of active cases at 11, same as the day before.
There is another cases in South East region, located in South East Zone 2 north of Zone 4.
There are 81 new cases of COVID-19 to report in Saskatchewan, along with 98 recoveries and one new death. Saskatchewan has now had 47,764 cases of COVID-19.
The other new cases in Saskatchewan are located in the following zones: Far North West, 3; Far North East, 4; North West, 13; North Central, 7; North East, 3; Saskatoon, 17; Central East, 3; Regina, 14; South West, 7; and South Central, 7. One case is pending residence information. One case with pending residence information was assigned to the Central East zone.
Fifteen cases tested out of province were added to the Far North East, 9; Far North West, 1; North East, 1; Saskatoon, 3; and South East, 1, zones.
One new death is being reported today in the 80+ age group from the Saskatoon zone.
A total of 554 people in Saskatchewan with COVID-19 have died.
Recoveries total 46,311. Three of the new recoveries are from the South East region.
A total of 899 cases are considered active, including 47 from the South East.
There are 104 people in hospital, including one receiving in-patient care in the southeast. Eighty-seven people are receiving inpatient care in Saskatchewan, including one out of province transfer from Manitoba, and 17 are in intensive care.
The seven-day average of new COVID-19 case number is 78 (6.4 per 100,000).
There were 2,165 COVID-19 tests processed in Saskatchewan on June 10, including 84 from the South East.
An additional 15,212 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 860,651. The South East accounted for 1,278 of the new doses.
Seventy-eight per cent of those over the age of 40 have received their first dose. Seventy-three per cent of those 30+ have received their first dose. Sixty-eight per cent of those 18+ have received their first dose, while sixty-six per cent of those 12+ have also received their first dose.